Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

AC Immune (ACIU) EBT Margin (2016 - 2025)

Historic EBT Margin for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to 1688.82%.

  • AC Immune's EBT Margin fell 17104100.0% to 1688.82% in Q3 2025 from the same period last year, while for Sep 2025 it was 1642.83%, marking a year-over-year decrease of 14969200.0%. This contributed to the annual value of 186.43% for FY2024, which is 1799100.0% up from last year.
  • Latest data reveals that AC Immune reported EBT Margin of 1688.82% as of Q3 2025, which was down 17104100.0% from 1622.43% recorded in Q2 2025.
  • In the past 5 years, AC Immune's EBT Margin ranged from a high of 1874700.0% in Q4 2022 and a low of 836700.0% during Q1 2021
  • For the 5-year period, AC Immune's EBT Margin averaged around 42790.59%, with its median value being 3312.95% (2024).
  • In the last 5 years, AC Immune's EBT Margin soared by 2000000000bps in 2022 and then plummeted by 2000000000bps in 2023.
  • Over the past 5 years, AC Immune's EBT Margin (Quarter) stood at 3693.23% in 2021, then skyrocketed by 50860bps to 1874700.0% in 2022, then crashed by -100bps to 1450.46% in 2023, then grew by 4bps to 1389.09% in 2024, then dropped by -22bps to 1688.82% in 2025.
  • Its EBT Margin stands at 1688.82% for Q3 2025, versus 1622.43% for Q2 2025 and 1922.12% for Q1 2025.